• AIM: To evaluate changes of proinflammatory cytokines in aqueous humor of patients with acute primary angleclosure (APAC) and age-related cataracts.
INTRODUCTION
A cute primary angle closure (APAC), one of the most serious ophthalmic emergencies, is characterized by a sudden rise in intraocular pressure (IOP) and structural damage, accompanied by severe inflammation in the anterior segment [1] . Studies have revealed that infectious inflammation and autoimmune inflammation have a role in the physiopathology of acute secondary angle closure, possibly by forming posterior synechiae leading to pupillary block and peripheral anterior synechiae [2] [3] . However, it has not been fully elucidated how proinflammatory conditions in the anterior segment contribute to the onset and development of APAC. Our previous studies showed that when compared with the cataract group, some general inflammatory cytokines in the aqueous, including interleukin (IL)-6, IL-8, granulocyte-colony stimulating factor, monocyte chemoattractant protein (MCP)-1, MCP-3, and vascular endothelial growth factor (VEGF), were significantly higher in primary angle-closure glaucoma patients [4] . However, studying only these inflammatory cytokines that mostly emerge at the peak of inflammation is insufficient to understand the exact role of inflammation in the onset and progression of APAC. Therefore, further exploration of proinflammatory cytokines which are more likely implicated in the early stage of inflammation may serve to provide a better understanding of the pathogenesis and development of APAC.
In this study, we focused on 20 proinflammatory cytokines in the aqueous humor of APAC eyes and investigated the possible roles of proinflammatory cytokines in the pathologic mechanism of APAC.
SUBJECTS AND METHODS

Subjects and Enrollment Criteria
The Ethical Review Committee of Zhongshan Ophthalmic Center approved this study. Informed consent forms were signed by all participants in this study in accordance with the tenets of the Declaration of Helsinki. All subjects were from the Chinese Han population and fulfilled the following inclusion criteria [5] : 1) presence of at least two of the following symptoms: ocular or periocular pain, nausea, and/or vomiting, and an antecedent history of intermittent blurring of vision with halos; 2) IOP of at least 22 mm Hg (as measured by Goldmann applanation tonometry); 3) presence of at least three of the following signs of conjunctival injection, corneal epithelial edema, middilated unreactive pupil, and shallow anterior chamber; 4) presence of an occluded angle in the affected eye, verified by gonioscopy. An ultrasound biomicroscopy (UBM) examination was performed on all of the eyes to confirm the presence of a narrow-angle pupillary block component. One eye of each subject was included. All eyes underwent thorough ophthalmic examinations, including IOP measurement (Goldmann applanation tonometry), slit-lamp biomicroscopy, gonioscopy, fundus examination, B-scanning and UBM. All of the APAC eyes underwent peripheral iridectomy or trabeculectomy. We standardized the antiglaucomatous medication treatment for APAC as described in our previous study [6] : topical pilocarpine 1% four times daily; topical β-blocker (timolol 0.5%) twice daily and/or brinzolamide (Azopt; Alcon Laboratories, Elkridge, MD, USA) and/or topical α-2 agonists (Alphagan; Allergan, Inc., Irvine, CA, USA); topical steroids; oral acetazolamide 250 mg three times daily; and intravenous mannitol 20% at 1-2 g/kg four hours after the initiation of the treatment when IOP was not reduced by 20% from the initial IOP, unless contraindicated by systemic disease (e.g. congestive heart failure).
Patients with age-related cataracts who underwent routine cataract surgery were included as controls. The enrolled cataract patients had normal IOP readings. Patients were excluded in the presence of any of the following criteria: a secondary acute attack due to lens subluxation, trauma, tumor, uveitis, iris neovascularization, or any obvious cataract leading to an intumescent lens; a known systemic inflammatory, autoimmune, or immunosuppressive disease; a preexisting ocular disease (e.g. retinal artery occlusion, retinal vein occlusion, age-related macular degeneration, diabetic retinopathy); or a history of previous ocular surgery. Patients with histories of chronic or intermittent angle closure were also excluded.
Aqueous Humor Collection
In accordance with the procedure described in our previous study [7] , aqueous humor samples (50-100 μL) were collected as follows: 1) samples were collected from the APAC eyes at the start of trabeculectomy or peripheral iridectomy; 2) samples were collected from the cataract eyes at the start of cataract surgery. To avoid the influence of surgical traumatic damage to the blood-aqueous barrier (BAB), all samples were obtained prior to any conjunctival or intraocular manipulation. All samples were immediately stored at -80 ℃ for later analysis. The minimum detectable concentration of the assay kit for these analytes varies from 0.3 pg/mL to 0.099 ng/mL, in accordance with the instruction manual. Statistical Analysis All the data in this study were processed and analyzed by SPSS (Version 17.0; SPSS, Chicago, IL, USA). The differences in cytokine levels between the two groups were analyzed with the Mann-Whitney U test. Figure 1 ; Table 2 ). Correlation Analysis The correlations between cytokine levels and age, elapsed time, and IOP2 are shown in IL-6 (P=0.012) and IL-27 (P=0.002). In addition, the levels of CCL20 and TNFα were also higher, whose P values (CCL20: P=0.057; TNFα:
P=0.056) almost reached the bound of 0.05. clinical samples, and found that APAC eyes had significantly elevated concentrations of IL-12, IL-15, IL-6, IL-27, CCL20, and TNFα. The levels of some cytokines were related to duration of the disease or age of the APAC patient. Both IL-12 and IL-27 belong to the IL-12 family and were upregulated in the aqueous humor of the APAC eyes in our study. IL-12 is a proinflammatory cytokine that has key roles in the development of Th1 cells and the subsequent immune cascades [8] [9] . While IL-27 has an anti-inflammatory effect by suppressing monocyte migration and neutrophil trafficking [10] , another key function is to regulate early inflammatory events during acute inflammation [11] . Therefore, IL-27 might be a protecting effector molecule of APAC. IL-12 and IL-27 performed inverse functions on inflammatory events in APAC eyes. How did interactions between IL-12 and IL-27 modulate early inflammation and its later development in APAC patients? These questions need to be investigated further. Monocyte/macrophage lineage and many other antigenpresenting cells can produce IL-15, which could stimulate the production and secretion of IL-8 by neutrophils, leading to further recruitment of neutrophils to the inflammatory site and augmenting the inflammation [12] . IL-15 is one of the earliest cytokines to be secreted promptly during an acute inflammatory state [13] . In the present study, IL-15 was upregulated in the aqueous humor of APAC eyes; it might trigger early inflammation in the anterior segment and contribute to the onset of APAC. Targeting the IL-15 pathway might serve to control the early proinflammatory state in the anterior segment of eyes and prevent APAC. IL-6, which is promptly and transiently produced in response to tissue injuries and immune reactions, issues a warning signal in the event of tissue damage [14] . In the current study, the aqueous level of IL-6 was higher in the APAC eyes than in the control cataract eyes, which may contribute to inflammatory damage in anterior segment of APAC eyes. IL-12, IL-15, IL6, and IL-27 are all closely associated with immune privilege within the eye. BAB dysfunction can contribute to the pathophysiology of inflammatory ocular diseases by allowing the leakage of molecules and inflammatory cells from the blood into the anterior segment of the eye [15] . Studies have shown that IL-12 can abrogate immune privilege within the anterior chamber by activating cytolytic T cells and inducing Th1 cells, which mediate delayed-type hypersensitivity [16] . IL-15, together with TNF, can potentially increase the permeability of the blood-brain barrier (BBB) by decreasing expression of the tight junction protein claudin-2 [17] . The structure of the BAB is very similar to that of the BBB; therefore, IL-15 and TNF might increase BAB permeability in APAC eyes. In addition, IL-6 can induce excess production of VEGF, leading to enhanced angiogenesis and increased vascular permeability [18] . To the contrary, it has been suggested that IL-27 contributes to ocular immune privilege presenting as BAB and blood-retina barrier [19] . It is possible that IL-12, IL-15, and IL-6 permeate the aqueous humor immediately through the BAB when damage occurs to the BAB structure. In turn, these cytokines might cooperate to promote disruption of the BAB, thus raising BAB permeability and leading to greater vascular leakage of molecules and inflammatory cells into the anterior segment of the eye. The inflammatory cells and these molecules in the aqueous humor may promote the onset of APAC by forming posterior synechiae, leading to pupillary block and peripheral anterior synechiae, and then may also exacerbate damage in APAC eyes directly. Conversely, IL-27 may serve as a protective factor in the remission state of APAC by maintaining ocular immune privilege. The different or even inverse roles of these cytokines in the pathologic mechanism of APAC through modulating the pathophysiological conditions of the BAB are complicated and need to be investigated further. In the present study, unexpectedly, the IOP measured just before surgery was not significantly correlated with the levels of any of the cytokines we detected. This is probably because the IOP before surgery was reduced by the antiglaucoma drugs. However, interestingly, the time elapsed between APAC onset and aqueous humor samples collection was positively correlated with levels of IL-27, IL-15, and TNFα. As mentioned above, IL-15, together with TNF, can increase BAB permeability, while IL-27 may serve to maintain ocular immune privilege. The balance of these cytokines may play an important role in the remission stage of inflammation in the anterior segment. Another finding was that age was positively correlated with levels of IL-12 and IL-6, both of which can induce or promote inflammation in eyes. This finding might indicate that it becomes easier for IL-12 and IL-6 to permeate aqueous humor through the BAB with increasing age. On one hand, these upregulated proinflammatory cytokines in aqueous humor might augment inflammation and exacerbate the damage associated with APAC. On the other hand, this result may provide another possible explanation for the higher incidence of APAC in older populations. Some potential limitations of this study should be mentioned. First, the use of topical antiglaucoma medications may influence the aqueous immune homeostasis. In the present study, the duration of medication use varied in the APAC patients due to different disease durations before surgery, which may be one of the factors generating the difference in cytokine levels. Another limitation was the sample size, as the number of subjects enrolled was relatively low. Larger patient populations might help strengthen the results and conclusions of this study. In summary, several proinflammatory cytokines, including IL-12，IL-15, IL-6 and IL-27, were upregulated in the aqueous humor of APAC eyes compared with control eyes with cataracts. These upregulated aqueous cytokines may be implicated in the pathogenesis and progression of APAC, but the exact mechanism need to be investigated further.
